Kooth vs Amgen

Side-by-side comparison of AI visibility scores, market position, and capabilities

Amgen leads in AI visibility (88 vs 52)
Kooth logo

Kooth

ChallengerHealthcare

Digital Mental Health & Wellbeing Platform for Young People

Kooth is a publicly traded UK digital mental health company (AIM: KOO) providing NHS-commissioned mental health services for under-18s; 2025 revenues of £63.3M; serves 20M+ people in the US and UK; operates in 3 U.S.

AI VisibilityBeta
Overall Score
C52
Category Rank
#279 of 596
AI Consensus
90%
Trend
stable
Per Platform
ChatGPT
57
Perplexity
58
Gemini
55

About

Kooth Digital Health is a UK-based digital mental health and wellbeing company founded in 2001, incorporated as a private limited company and publicly listed on the London Stock Exchange AIM market under the ticker KOO. Kooth is the largest single-access provider of digital mental health services for children and young people under 18 in NHS England, providing free, accessible, clinically robust support with no waiting lists. The platform gives young people aged 11 to 25 access to an online community of peers, structured self-help content, and a team of experienced counsellors — available through web and mobile, with no referral required.

Full profile
Amgen logo

Amgen

LeaderHealthcare Tech

AI Drug Discovery

Amgen (AMGN) reported $33.4B revenue in FY2024, up 19% YoY (post-Horizon acquisition). Top-5 global biotech. 10+ blockbuster drugs. ~24,000 employees. HQ: Thousand Oaks, CA. Market cap ~$130B.

AI VisibilityBeta
Overall Score
A88
Category Rank
#3 of 596
AI Consensus
78%
Trend
stable
Per Platform
ChatGPT
83
Perplexity
87
Gemini
85

About

Amgen Inc. is one of the world's largest biotechnology companies, headquartered in Thousand Oaks, California. Founded in 1980 as Applied Molecular Genetics, Amgen pioneered the development of biologics and brought landmark medicines including Epogen, Neupogen, and Enbrel to market. The company reported revenues of $33.4B in FY2024, up 19% year-over-year, boosted by the transformational $28B acquisition of Horizon Therapeutics in October 2023.

Full profile

AI Visibility Head-to-Head

52
Overall Score
88
#279
Category Rank
#3
90
AI Consensus
78
stable
Trend
stable
57
ChatGPT
83
58
Perplexity
87
55
Gemini
85
55
Claude
90
54
Grok
92

Key Details

Category
Digital Mental Health & Wellbeing Platform for Young People
AI Drug Discovery
Tier
Challenger
Leader
Entity Type
brand
company

Capabilities & Ecosystem

Capabilities

Only Amgen
AI Drug Discovery

Integrations

Amgen is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.